Key Market Indicators
Sales of beta blocking medicines in Finland are projected to decline from $24.09 million this year to around $18.6 million in 2026. Since 2003, the Finnish market has decreased by an average rate of 3.6% annually. Slovakia was the leader in 2021 with total sales of $24.09 million. Italy, Canada, and Australia followed in second, third, and fourth place respectively.